Contract Assay Services
Partner with the multi-omics industry leader to advance your clinical programs through customized laboratory test development, validation, and performance, backed by long-term support.
Scale Clinical Impact Through One End-to-End Genomics Partnership
Streamline complex projects with fully customizable solutions. Through deep expertise, Broad Clinical Labs’ Contract Assay Services deliver tailored clinical study solutions that scale to advance multi-phase projects—from concept to real-world application.
Collaborate with us at any phase of your project to ensure scalable, scientifically aligned solutions that maximize clinical development success.
Expert Consultation and Collaboration
Leverage over 30 years of innovation experience through our cross-functional team of experts who operate as an extension of your team, bringing deep multi-omic knowledge to develop and validate robust clinical assays that advance your therapeutic and diagnostic initiatives.
Scalable Sequencing Services
Access customizable sequencing technologies operating in our CLIA-licensed and CAP-accredited facilities, with scalable high-throughput infrastructure that delivers consistent regulatory-grade quality across complex, multi-phase studies.
End-to-End Partnership
Eliminate fragmented workflows with a single, trusted partner providing seamless continuity through all project phases, from planning and assay development to high-throughput processing and analysis.
Patient-Partnered Research Solutions
Optimize your population research by leveraging our expertise in collaborative study design, integrated patient and stakeholder engagement services, and efficient direct-to-patient kitting for successful execution across diverse patient communities.
Partnership at Every Stage: From Strategy to Success
Partner with us at any point in your project lifecycle—from early strategic consultation to scaling existing research initiatives or ongoing project support. Our flexible engagement model ensures you receive expert guidance and seamless execution at every phase.
Planning
Strategic consultation on study design, assay selection, and budgeting to ensure scalable, scientifically-aligned solutions and strong research proposals.
Development
Development and validation of fit-for-purpose assays that generate reliable multi-omic insights tailored to your specific research objectives and regulatory requirements.
Execution
High-throughput sample processing and integrated multi-omic data generation through our scalable automation infrastructure.
Ongoing Support
Continuous testing, analysis, and dedicated account management for long-term follow-up studies and real-world evidence generation throughout your project lifecycle.
Planning
Strategic consultation on study design, assay selection, and budgeting to ensure scalable, scientifically-aligned solutions and strong research proposals.
Development
Development and validation of fit-for-purpose assays that generate reliable multi-omic insights tailored to your specific research objectives and regulatory requirements.
Execution
High-throughput sample processing and integrated multi-omic data generation through our scalable automation infrastructure.
Ongoing Support
Continuous testing, analysis, and dedicated account management for long-term follow-up studies and real-world evidence generation throughout your project lifecycle.
How can we support your clinical research, diagnostic, or therapeutic development journey?
Partnerships Advancing Clinical Breakthroughs
Leading institutions partner with Broad Clinical Labs to advance their most ambitious projects, achieving breakthroughs that transform patient outcomes and accelerate innovation.
Advancing Pediatric Cancer Diagnostics
Boston Children’s Hospital and Dana-Farber Cancer Institute partnered with us to develop BrightSeq, a groundbreaking initiative transforming how rare pediatric cancers are detected and monitored. Leveraging Broad Clinical Lab’s precision genomics, liquid biopsy technologies, and scalable clinical operations, this innovative collaboration provides critical diagnostic insights while advancing pediatric cancer research globally.
Expanding Access to Infectious Disease Diagnostics
Accelerated by our partnership, Delve Bio scaled their metagenomic next-generation sequencing platform nationwide, providing rapid answers for patients with complex neurological infections. With the support of Broad Clinical Labs’ high-throughput capabilities and expertise, Delve Bio is enabling clinicians to achieve definitive diagnoses for challenging cases of meningitis and encephalitis in just two days.